NM_000537.4:c.1184G>A
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_000537.4(REN):c.1184G>A(p.Arg395Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R395W) has been classified as Uncertain significance.
Frequency
Consequence
NM_000537.4 missense
Scores
Clinical Significance
Conservation
Publications
- familial juvenile hyperuricemic nephropathy type 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- renal tubular dysgenesis of genetic originInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
REN | ENST00000272190.9 | c.1184G>A | p.Arg395Gln | missense_variant | Exon 10 of 10 | 1 | NM_000537.4 | ENSP00000272190.8 | ||
REN | ENST00000638118.1 | c.1070G>A | p.Arg357Gln | missense_variant | Exon 12 of 12 | 5 | ENSP00000490307.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461836Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727214 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Familial juvenile hyperuricemic nephropathy type 2 Uncertain:1
The detected change is not reported in the general population (gnomAD) (as of October 10, 2023). It has not yet been described in the ClinVar database or in the literature. From a bioinformatic perspective, the change is inconsistently classified as disease-causing (CADDphred 28.4, PolyPhen2), but also as “tolerated” and “benign” (SIFT, MutationTaster). The variant is currently considered a “variant of uncertain clinical significance” (ACMG criteria). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at